What are the major challenges facing the Single-ventricular Extracorporeal Life Support Devices market?

High costs and limited availability of devices are major challenges facing the market.

Who are the top companies in the Single-ventricular Extracorporeal Life Support Devices market?

Leading companies include Medtronic, Abbott, and Getinge, which offer a range of devices.

What future opportunities exist in the Single-ventricular Extracorporeal Life Support Devices market?

Emerging markets and innovative technologies offer significant future opportunities for growth.

What is the current regulatory landscape for the Single-ventricular Extracorporeal Life Support Devices market?

The market is regulated by stringent FDA and CE markings, ensuring device safety and efficacy.

What is the future outlook for the Single-ventricular Extracorporeal Life Support Devices market?

The future outlook is positive, with increasing demand and advances in technology driving market growth.

Single-ventricular Extracorporeal Life Support Devices - Strategic Insights: Analysis 2025 and Forecasts 2033

Single-ventricular Extracorporeal Life Support Devices by Application (Hospital, Specialty Clinic, Other), by Types (VA, VV), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Single-ventricular Extracorporeal Life Support Devices Market Overview

The Single-ventricular Extracorporeal Life Support Devices market refers to the industry that provides life-supporting devices for patients with cardiac failure. As the Single-ventricular Extracorporeal Life Support Devices market size is expected to reach $235 million by 2026, the growth outlook and market forecast indicate a promising industry expansion. The scope of this market encompasses various types of devices, including extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs), which are used in hospitals, clinics, and other healthcare settings. The current market size is approximately $143 million, with a growth forecast of 8% CAGR from 2026 to 2033. Key forces shaping the industry include technology shifts, such as the development of more portable and user-friendly devices, regulations governing the approval and use of these devices, and consumer behavior, with an increasing demand for life-supporting therapies.

Loading chart…

The largest region in the Single-ventricular Extracorporeal Life Support Devices market is North America, while the fastest-growing region is Asia-Pacific. The growth outlook for this market is driven by the increasing incidence of cardiac failure, advancements in technology, and the growing demand for life-supporting therapies. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, developments, and market forecast to make strategic decisions and stay ahead of the competition. The industry expansion is expected to be driven by the increasing adoption of extracorporeal life support devices in hospitals and clinics, as well as the growing demand for portable and user-friendly devices.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LivaNova; MAQUET Holding; Medtronic; Microport Scientific; Sorin Group; Nipro Medical; Terumo Cardiovascular Systems; Medos Medizintechnik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Single-ventricular Extracorporeal Life Support Devices market is poised for significant growth, driven by various factors. The growth forecast for the Single-ventricular Extracorporeal Life Support Devices market size is expected to be substantial, with key drivers influencing the market's trajectory.

Growth Drivers2 items

Increasing demand for extracorporeal life support systems in cardiac and respiratory care, driven by the growing prevalence of chronic diseases and critical care requirements

Advancements in technology and innovation in Single-ventricular Extracorporeal Life Support Devices, enabling improved patient outcomes and efficiency in clinical settings

Restraints2 items

High cost of Single-ventricular Extracorporeal Life Support Devices and associated maintenance and training requirements, limiting adoption in resource-constrained healthcare settings

Stringent regulatory requirements and quality control measures, potentially hindering the development and commercialization of new Single-ventricular Extracorporeal Life Support Devices

Opportunities2 items

Expanding applications of Single-ventricular Extracorporeal Life Support Devices in neonatal and pediatric care, as well as in emergency and trauma situations

Growing demand for portable and compact Single-ventricular Extracorporeal Life Support Devices, driven by the need for mobility and flexibility in critical care settings

Challenges2 items

Managing the complexity of Single-ventricular Extracorporeal Life Support Devices and ensuring operator competence, to minimize adverse events and optimize patient outcomes

Addressing the reimbursement and funding challenges associated with the adoption of Single-ventricular Extracorporeal Life Support Devices, particularly in low-resource healthcare systems

Market Segmentation

Loading chart…

The Single-ventricular Extracorporeal Life Support Devices market can be segmented based on application, which includes hospital and clinic settings. This segmentation contributes to the overall Single-ventricular Extracorporeal Life Support Devices market size, as it helps in understanding the demand for these devices in different healthcare settings. The application segment is crucial in the Single-ventricular Extracorporeal Life Support Devices segmentation, as it enables manufacturers to develop targeted marketing strategies and tailor their products to meet the specific needs of various healthcare facilities.

The types of Single-ventricular Extracorporeal Life Support Devices include pump-based and pumpless devices. Pump-based devices use a mechanical pump to circulate blood, while pumpless devices rely on the patient's native heart function to circulate blood. This segmentation is essential in understanding the market size and growth prospects of the Single-ventricular Extracorporeal Life Support Devices market, as it helps in identifying the most widely used and preferred types of devices. The types segment is vital in the market taxonomy, as it allows manufacturers to focus on developing innovative products that cater to the evolving needs of the healthcare industry.

Single-ventricular Extracorporeal Life Support Devices Segmentation Breakdown7 items

Application

Hospital

Specialty Clinic

Other

Types

Regional Insights

Loading chart…

The Single-ventricular Extracorporeal Life Support Devices market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers comprise a strong regulatory framework, increasing adoption of single-ventricular support devices, and a large patient population. Asia Pacific's growth is fueled by a rapidly developing ecosystem, rising demographics, and growing investments in healthcare. Latin America's market is driven by improving infrastructure and increasing adoption, while the Middle East & Africa region is expected to grow due to rising policies support and growing investments in healthcare.

Regional forecast indicates that Asia Pacific will experience the highest regional forecast growth rate, driven by the aforementioned factors. As the Single-ventricular Extracorporeal Life Support Devices market continues to evolve, understanding regional dynamics will be crucial for stakeholders to capitalize on emerging opportunities and navigate challenges.

Competitive Landscape

The Single-ventricular Extracorporeal Life Support Devices market is moderately consolidated, driven by a mix of global players and local companies. The Single-ventricular Extracorporeal Life Support Devices competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies emphasize regional expansion and localization to compete effectively.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must adapt to changing market dynamics and focus on strategic initiatives.

LivaNova: regional expansion

MAQUET Holding: vertical integration

Medtronic: innovation pipeline

Microport Scientific: OEM tie-ups

Sorin Group: premium pricing

Nipro Medical: local manufacturing

Key Single-ventricular Extracorporeal Life Support Devices Companies8 items

LivaNova

MAQUET Holding

Medtronic

Microport Scientific

Sorin Group

Nipro Medical

Terumo Cardiovascular Systems

Medos Medizintechnik

Market Ecosystem

The Single-ventricular Extracorporeal Life Support Devices ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers, midstream integrators and manufacturers, to downstream channels and end users. This ecosystem is characterized by a sequence of value-creating activities, from component sourcing to device assembly, and ultimately, to patient care. Understanding the boundaries and interactions within this ecosystem is crucial for navigating the Single-ventricular Extracorporeal Life Support Devices ecosystem and identifying opportunities for growth and innovation.

Raw material/component suppliers — provide critical device components

OEMs / manufacturers — design and assemble devices

System integrators / EPCs — integrate devices into healthcare systems

Distributors / channel partners — facilitate device distribution

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize devices in patient care

Regulators/standards bodies — establish device safety and efficacy standards

Value flows through the Single-ventricular Extracorporeal Life Support Devices ecosystem as participants interact and exchange goods, services, and information. Control points, such as regulatory bodies and device manufacturers, influence adoption and usage. Dependency risks, including input constraints and standards approvals, can impact the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can affect participants' ability to navigate the ecosystem. The ecosystem's dynamics can also vary by region, with different countries having distinct regulatory frameworks, healthcare systems, and market demands.

Recent Industry Insights

The Single-ventricular Extracorporeal Life Support Devices industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key market players have focused on enhancing product offerings and expanding global reach. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the market. Furthermore, several product and technology launches have improved the efficacy and safety of Single-ventricular Extracorporeal Life Support Devices, driving growth in the industry.

Regulatory changes have also played a crucial role in shaping the Single-ventricular Extracorporeal Life Support Devices industry trends. Shifts in consumer and enterprise trends have led to increased demand for more advanced and user-friendly devices. Additionally, funding rounds and expansions have enabled companies to invest in research and development, driving innovation in the industry. These developments are expected to continue shaping the Single-ventricular Extracorporeal Life Support Devices industry trends in the coming years.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Single-ventricular Extracorporeal Life Support Devices market outlook. The market exhibits moderate attractiveness due to the increasing demand for extracorporeal life support devices in critical care settings. The competitive intensity is relatively high, with key players competing for market share. The long-term outlook remains positive, driven by advancements in medical technology and growing healthcare expenditure.

The innovation landscape is characterized by ongoing research and development in single-ventricular support systems, which is expected to drive growth. However, the demand–supply balance may be affected by regulatory challenges and supply chain disruptions. Key risk factors include reimbursement uncertainties and competitive pricing pressures. Overall, the Single-ventricular Extracorporeal Life Support Devices market outlook is promising, with opportunities for growth and innovation in the coming years.

12 items

1. Executive Summary

2. Single-ventricular Extracorporeal Life Support Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single-ventricular Extracorporeal Life Support Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Single-ventricular Extracorporeal Life Support Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Single-ventricular Extracorporeal Life Support Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Single-ventricular Extracorporeal Life Support Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Single-ventricular Extracorporeal Life Support Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Single-ventricular Extracorporeal Life Support Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Single-ventricular Extracorporeal Life Support Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Single-ventricular Extracorporeal Life Support Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Single-ventricular Extracorporeal Life Support Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Single-ventricular Extracorporeal Life Support Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single-ventricular Extracorporeal Life Support Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Single-ventricular Extracorporeal Life Support Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Single-ventricular Extracorporeal Life Support Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Single-ventricular Extracorporeal Life Support Devices Market Competition by Key Manufacturers

9.1. Global Single-ventricular Extracorporeal Life Support Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Single-ventricular Extracorporeal Life Support Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. LivaNova

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. MAQUET Holding

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medtronic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Microport Scientific

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Sorin Group

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Nipro Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Terumo Cardiovascular Systems

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Medos Medizintechnik

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single-ventricular Extracorporeal Life Support Devices Market

Figure 4: Global Single-ventricular Extracorporeal Life Support Devices Market: Drivers

Figure 5: Global Single-ventricular Extracorporeal Life Support Devices Market: Challenges

Figure 6: Global Single-ventricular Extracorporeal Life Support Devices Market: Trends

Figure 7: Global Single-ventricular Extracorporeal Life Support Devices Market: Opportunity

Figure 8: Global Single-ventricular Extracorporeal Life Support Devices Market: Restraint

Figure 9: Global Single-ventricular Extracorporeal Life Support Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Single-ventricular Extracorporeal Life Support Devices Market Value (USD Million) By Region

Figure 19: Global Single-ventricular Extracorporeal Life Support Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Single-ventricular Extracorporeal Life Support Devices Market Value (USD Million) By Region

Figure 27: Global Single-ventricular Extracorporeal Life Support Devices Market Share (%) By: Regions (2032)

Figure 28: Global Single-ventricular Extracorporeal Life Support Devices Market Volume (K) By Region

Figure 29: Global Single-ventricular Extracorporeal Life Support Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Single-ventricular Extracorporeal Life Support Devices Market Value (USD Million) By Region

Figure 37: Global Single-ventricular Extracorporeal Life Support Devices Market Share (%) By: Regions (2032)

Figure 38: Global Single-ventricular Extracorporeal Life Support Devices Market Volume (K) By Region

Figure 39: Global Single-ventricular Extracorporeal Life Support Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

111 items

Table 1: Market Segmentation Analysis

Table 2: Global Single-ventricular Extracorporeal Life Support Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Single-ventricular Extracorporeal Life Support Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Single-ventricular Extracorporeal Life Support Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Single-ventricular Extracorporeal Life Support Devices Market Value (USD Million) By Region

Table 14: Global Single-ventricular Extracorporeal Life Support Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Single-ventricular Extracorporeal Life Support Devices Market Volume (K) By Region

Table 31: Global Single-ventricular Extracorporeal Life Support Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Single-ventricular Extracorporeal Life Support Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Single-ventricular Extracorporeal Life Support Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Single-ventricular Extracorporeal Life Support Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: LivaNova Basic Information And Sales Area

Table 52: LivaNova. Products Portfolio

Table 53: MAQUET Holding Basic Information And Sales Area

Table 54: MAQUET Holding. Products Portfolio

Table 55: Medtronic Basic Information And Sales Area

Table 56: Medtronic. Products Portfolio

Table 57: Microport Scientific Basic Information And Sales Area

Table 58: Microport Scientific. Products Portfolio

Table 59: Sorin Group Basic Information And Sales Area

Table 60: Sorin Group. Products Portfolio

Table 61: Nipro Medical Basic Information And Sales Area

Table 62: Nipro Medical. Products Portfolio

Table 63: Terumo Cardiovascular Systems Basic Information And Sales Area

Table 64: Terumo Cardiovascular Systems. Products Portfolio

Table 65: Medos Medizintechnik Basic Information And Sales Area

Table 66: Medos Medizintechnik. Products Portfolio

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Value (USD Million) (2025-2032) By Types

Table 70: Global Market Share (%) By Types (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Volume (K) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Single-ventricular Extracorporeal Life Support Devices Market Value (USD Million) By Region

Table 76: Global Single-ventricular Extracorporeal Life Support Devices Market Share (%) By Region (2025-2032)

Table 77: North America Market Value (USD Million) (2025-2032) By Country

Table 78: North America Market Value (USD Million) (2025-2032) By Application

Table 79: North America Market Value (USD Million) (2025-2032) By Types

Table 80: Europe Market Value (USD Million) (2025-2032) By Country

Table 81: Europe Market Value (USD Million) (2025-2032) By Application

Table 82: Europe Market Value (USD Million) (2025-2032) By Types

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 86: South America Market Value (USD Million) (2025-2032) By Country

Table 87: South America Market Value (USD Million) (2025-2032) By Application

Table 88: South America Market Value (USD Million) (2025-2032) By Types

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 92: Global Single-ventricular Extracorporeal Life Support Devices Market Volume (K) By Region

Table 93: Global Single-ventricular Extracorporeal Life Support Devices Market Share (%) By Region (2025-2032)

Table 94: North America Market Volume (K) (2025-2032) By Country

Table 95: North America Market Volume (K) (2025-2032) By Application

Table 96: North America Market Volume (K) (2025-2032) By Types

Table 97: Europe Market Volume (K) (2025-2032) By Country

Table 98: Europe Market Volume (K) (2025-2032) By Application

Table 99: Europe Market Volume (K) (2025-2032) By Types

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 101: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 103: South America Market Volume (K) (2025-2032) By Country

Table 104: South America Market Volume (K) (2025-2032) By Application

Table 105: South America Market Volume (K) (2025-2032) By Types

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 107: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 109: Research Programs/Design For This Report

Table 110: Key Data Information From Secondary Sources

Table 111: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Single-ventricular Extracorporeal Life Support Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	LivaNova; MAQUET Holding; Medtronic; Microport Scientific; Sorin Group; Nipro Medical; Terumo Cardiovascular Systems; Medos Medizintechnik
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for extracorporeal life support systems in cardiac and respiratory care, driven by the growing prevalence of chronic diseases and critical care requirements

Advancements in technology and innovation in Single-ventricular Extracorporeal Life Support Devices, enabling improved patient outcomes and efficiency in clinical settings

Restraints2 items

High cost of Single-ventricular Extracorporeal Life Support Devices and associated maintenance and training requirements, limiting adoption in resource-constrained healthcare settings

Stringent regulatory requirements and quality control measures, potentially hindering the development and commercialization of new Single-ventricular Extracorporeal Life Support Devices

Opportunities2 items

Expanding applications of Single-ventricular Extracorporeal Life Support Devices in neonatal and pediatric care, as well as in emergency and trauma situations

Growing demand for portable and compact Single-ventricular Extracorporeal Life Support Devices, driven by the need for mobility and flexibility in critical care settings

Challenges2 items

Managing the complexity of Single-ventricular Extracorporeal Life Support Devices and ensuring operator competence, to minimize adverse events and optimize patient outcomes

Addressing the reimbursement and funding challenges associated with the adoption of Single-ventricular Extracorporeal Life Support Devices, particularly in low-resource healthcare systems

Market Segmentation

Loading chart…

Single-ventricular Extracorporeal Life Support Devices Segmentation Breakdown7 items

Application

Hospital

Specialty Clinic

Other

Types

Regional Insights

Loading chart…

Competitive Landscape

LivaNova: regional expansion

MAQUET Holding: vertical integration

Medtronic: innovation pipeline

Microport Scientific: OEM tie-ups

Sorin Group: premium pricing

Nipro Medical: local manufacturing

Key Single-ventricular Extracorporeal Life Support Devices Companies8 items

LivaNova

MAQUET Holding

Medtronic

Microport Scientific

Sorin Group

Nipro Medical

Terumo Cardiovascular Systems

Medos Medizintechnik

Market Ecosystem

Raw material/component suppliers — provide critical device components

OEMs / manufacturers — design and assemble devices

System integrators / EPCs — integrate devices into healthcare systems

Distributors / channel partners — facilitate device distribution

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize devices in patient care

Regulators/standards bodies — establish device safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents